| |
|
|
|
Entera Bio Ltd  
|
|
1.1 0.01 (0.01%) |
10-23 16:00 |
|
Open: |
1.11 |
Pre close: |
1.09 |
Target:
|
1.55
|
|
High: |
1.11 |
Low: |
1.085 |
Resistance:
|
1.33
1.50
|
|
Volume: |
15,216 |
Market Cap: |
20M |
Support:
|
1.05
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.10
 |
MACD |
MACD(12,26):
|
-0.05  |
|
MA(20): |
1.16 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
1.53 |
Stochastic Oscillator |
%K(14,3):
|
22.22 |
|
MA(250): |
2.06 |
%D(3): |
19.02 |
|
Average Volume(K) |
3-Month: |
15269
|
52-Week |
High:
|
3.40 |
|
10-Days: |
3168 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
39.83 |
Change(%): |
-58.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.815 |
Return on Equity (ttm) |
-183.1 |
Shares Out. (M) |
18.23 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-77.7 |
Shares Float (M) |
8.85 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.22 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-29.7 |
% Held by Institutions |
10.55 |
|
Forward EPS |
1.310 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
26 |
|
Book Value (p.s.) |
0.400 |
EBITDA (p.s.) |
-0.695 |
P/E |
-1.35 |
|
Sales Per Share |
0.014 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.75 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.04 |
P/S |
78.33 |
|
Operating Margin |
-4982.81 |
Levered Free Cash Flow
(M) |
-3.95 |
P/CF |
-1.82 |
|
|
|
|
|
|
